Brief: Malin Corp Reduces 2026 Year End Valuation Of Kymab Contingent Consideration To Nil
27/07/2026 18:37
BRIEF-Malin Corp Reduces 2026 Year End Valuation Of Kymab Contingent Consideration To Nil July 27 (Reuters) - Malin Corporation PLC MLCM.I:
MALIN CORP PLC - INVESTEE COMPANY UPDATE
MALIN - REDUCES 2026 YEAR END VALUATION OF KYMAB CONTINGENT CONSIDERATION TO NIL
Source text: ID:nRSa0512Oa
Further company coverage: MLCM.I